|
 |
PramipexoleThis page contains recent news articles, when available, and an overview of Pramipexole but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Pramipexole (when available) Pramipexole is a nonergot dopamine agonist with high relative in vitro specificity and full intrinsic activity at the D2 subfamily of dopamine receptors, binding with higher affinity to D3 than to D2 or D4 receptor subtypes. The relevance of D3 receptor binding in Parkinson's disease is unknown. The precise mechanism of action of Pramipexole as a treatment for Parkinson's disease is unknown, although it is believed to be related to its ability to stimulate dopamine receptors in the striatum. This conclusion is supported by electrophysiologic studies in animals that have demonstrated that Pramipexole influences striatal neuronal firing rates via activation of dopamine receptors in the striatum and the substantia nigra, the site of neurons that send projections to the striatum. For the treatment of signs and symptoms of idiopathic Parkinson's disease Mechanism Of Action: The precise mechanism of action of Pramipexole as a treatment for Parkinson's disease is unknown, although it is believed to be related to its ability to stimulate dopamine receptors in the striatum. News Articles on Pramipexole $8.2 Judgment Against Parkinson's Drug Mirapex - Aug 1, 2008 Altogether he was prescribed Mirapex (Pramipexole) to treat Parkinson’s for eight years beginning in 1997. The litigation is the first in a series of more InjuryBoard.com, Pharmacoeconomics of Parkinson's Disease - Jul 31, 2008 Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA. 2002;287:1653-1661. Medscape (subscription) Restless Legs Syndrome - Jul 16, 2008 Pramipexole (Mirapex) and ropinirole (Rrequip) are both indicated for the treatment of moderate to severe RLS. dopamine agonist dosing for RLS is lower than RedOrbit, Restless Legs Syndrome may be mental or genetic - Aug 4, 2008 The FDA then approved pramipexole (Mirapex) in 2006. Clinical trials have also found several drugs used to treat other conditions helpful in treating RLS, News 8 Austin, Bipolar Disorder Detection and Management - Jul 17, 2008 ...[28] Adjunctive pramipexole, a dopamine D 2 /D 3 receptor agonist, has also been shown to have some efficacy in the treatment of bipolar depression in 2 Medscape (subscription) Witty says GSK must change as strategic shift is outlined - Jul 24, 2008 Sales of the heart disease drug Coreg (carvedilol) sank 97% to just £5 million, while ReQuip (pramipexole), for Parkinson’s disease and restless legs Pharma Times (subscription), Search this blog - Jul 15, 2008 When patented medicines [Requip (ropinirole) and Mirapex (pramipexole)] became available, RLS became an opportunity, hence, the ads. ScienceBlogs ì¤‘ì¶”ì‹ ê²½ê³„ì•½ ì œë„¤ë¦ ì—¬íŒŒ â€˜ì œê°?ê°?’ - Jul 14, 2008 ...파킨슨병 ì¹˜ë£Œì œì?˜ 경우ì—?ë?„ 2012년까지 ë?„파민 길í•ì œì?¸ '미ë?¼íŽ™ìŠ¤'(Mirapex, pramipexole)와 'ë ˆí?…'(Requip, ropinirole)ì?´, 향후 10ë…„ ì?´ë‚´ 'ìŠ¤íƒ€ë ˆë³´'(Stalevo, 디지틀보사, Parkinson's drug listed on PBS - 02 Jun 2008 Pramipexole imitates the natural chemical dopamine, which controls movement and co-ordination and is reduced in Parkinson's sufferers. The Age, Parkinson's diease drug in clear despite fears - 02 Jun 2008 Pramipexole is one of a number of drugs for Parkinson's that are known to cause compulsive behaviour in about 20 per cent of patients. The Australian, Neural Stimulation Successfully Treats Depression in Patients With ... - 02 Jun 2008 Ms. A had also tried venlafaxine and pramipexole but was unable to tolerate these medications before conventional therapeutic doses were reached. Am J Psychiatry (subscription) Drugs for Restless Legs Syndrome Have Downsides - May 12, 2008 The other three, pramipexole (Mirapex), ropinirole (Requip) and rotigotine (Neupro) are the mainstays of treatment for a condition that affects 5 percent to Forbes, Nonergot Dopamine Agonists Helpful for Restless Legs Syndrome - May 12, 2008 The reviewers performed a systematic search of the literature through July 2007 for studies of NEDA (pramipexole, ropinirole, rotigotine, and sumanirole) Medscape (subscription) 1 in 12 teens depressed - May 18, 2008 White and his colleagues looked at trials of three nonergot dopamine agonist (NEDA) drugs: pramipexole (Mirapex), ropinirole (Requip) and rotigotine Chicago Tribune, Without TV ads, restless legs may take a hike - May 14, 2008 Representatives for Boehringer-Ingelheim, the makers of Mirapex, the brand name for pramipexole, declined to discuss whether their advertising strategy MSNBC Incidence, Impact, and Current Management Strategies for Treatment ... - May 22, 2008 Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review. Ann Clin Psychiatry 2000;12(3):137-140. Medscape (subscription) When you get sick, do you call a doctor or a lawyer? - May 8, 2008 Get a glimpse of that by Googling “drug package insertsâ€? and discovering phrases like: “the influence of hepatic insufficiency on pramipexole Capitol Weekly, New Data Confirm Pramipexole (Mirapexin®/Sifrol®) Can ... - Apr 21, 2008 A new study has shown that pramipexole (Mirapexin®/Sifrol®) can significantly reduce sleep disturbance, often the most troublesome symptom experienced by Medical News Today (press release), Sleep Disturbance Reduced for Patients With Restless Legs Syndrome ... - Apr 18, 2008 By Ed Susman CHICAGO -- April 18, 2008 -- Sleep disturbance scores were reduced nearly 50% in patients with restless legs syndrome treated with pramipexole, DG News Leg problems keeping you up at night? - Apr 15, 2008 Other medications that may help include: Pramipexole, a medicine that works in a similar way as ropinirole; Clonazepam (Klonopin), triazolam (Halcion), Times Daily (subscription), Boehringer sails on serenely despite impending Flomax patent expiry - Apr 9, 2008 ...as well as the loss of protection in some smaller markets on Sifrol/Mirapex (pramipexole) for Parkinson's disease and restless legs syndrome, Pharma Times (subscription), Boehringer Ingelheim outpaces the market yet again in 2007 - Apr 8, 2008 In addition, Sifrol®/Mirapex® (pramipexole) for the symptomatic treatment of Parkinson`s disease and for the treatment of moderate to severe cases of PharmaLive.com (press release), Knopp Neurosciences Initiates Phase 2 Study of KNS-760704 in ... - Apr 7, 2008 Like its S(-) optical enantiomer, pramipexole dihydrochloride (Mirapex ® ), KNS-760704 has been shown to be effective in a range of neuroprotective assays. Business Wire (press release), Researchers work in county to improve Parkinson's drugs - Mar 29, 2008 The Pacific Neuroscience Medical Group in Oxnard is also accepting people with Parkinson's into clinical studies for a drug called Pramipexole. Ventura County Star, Barr gets FDA OK for generic Mirapex - Feb 19, 2008 The Food and Drug Administration approved Barr's abbreviated new drug application for pramipexole dihydrochloride (Mirapex) at 0.125, 0.25, 0.5, Forbes, Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125 ... - Feb 19, 2008 Under the terms of a Court Order, Barr has agreed not to launch its Pramipexole Dihydrochloride tablets product until the earliest of the following occurs: Earthtimes, Fresh hope: Drug shows promise for ALS sufferers - Feb 14, 2008 His study, he says, supports his early hypothesis that the compound known as pramipexole is safe, even at the higher doses required to protect nerve cells, The Hook, Barr Prepares to Launch Mirapex This Year - Feb 27, 2008 Mirapex (pramipexole dihydrochloride) is indicated for treating the signs and symptoms of idiopathic Parkinson’s disease. The patent trial is scheduled to FDA news (subscription), On the Pulse - 15th February - Feb 15, 2008 After years of exhaustive investigation without either diagnosis or useful treatment, a friend with restless legs syndrome offered pramipexole. OnMedica, Daily Briefs: Funkhouser's Budget; Wal-Mart; Someday, Overland ... - Feb 15, 2008 It's actually an extra-large pramipexole dihydrochloride variant made for horses, but believe me, my restless-leg syndrome is fucking out of control, Pitch Weekly, Restless Legs Syndrome is Associated with DSM-IV Major Depressive ... - Feb 27, 2008 CJ: Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Journal of Neuropsychiatry (subscription) Study looks at use of drug to slow progress of Parkinson's - Jan 24, 2008 Rush is looking for volunteers recently diagnosed with Parkinson’s to participate in a national clinical study of the drug pramipexole. Medill Reports, Stakeholder Insight: Parkinson's Disease - Evidence of ... - Feb 5, 2008 Neurologists indicated that the DAs Mirapex (pramipexole) and Requip (ropinirole) are generally the initial treatment of choice for younger presenting Business Wire (press release), Knopp Neurosciences Completes First Series B Financing of $10 Million - Jan 22, 2008 Like its S(-) optical enantiomer, pramipexole dihydrochloride (Mirapex ® ), KNS-760704 has been shown to be effective in a range of neuroprotective assays. Business Wire (press release), Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage ... - Dec 12, 2007 Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. Web Services Journal, Knopp Neurosciences Presents Results of Phase 1 Ascending Single ... - Dec 3, 2007 A single 300 mg dose of KNS-760704 is 2400 times higher than the recommended starting dose of Mirapex® (pramipexole), which is the (S)-optical enantiomer of Business Wire (press release), Barr says US tentatively oks its generic Mirapex - Oct 30, 2007 Barr said the US Food and Drug Administration has given tentative approval to its tablet forms of the medicine, the chemical name of which is pramipexole, Reuters Barr Pharmaceuticals Inc announces tentative approval from FDA for ... - Oct 31, 2007 Mirapex (Pramipexole Dihydrochloride) tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease. Trading Markets (press release), Barr Receives Tentative Approval for Generic Version of Mirapex - Nov 1, 2007 Barr filed its abbreviated new drug application for generic Mirapex (pramipexole dihydrochloride) 0.25 mg in May 2005. A month later, the company amended FDA news (subscription), Barr Gets FDA Nod for Generic Mirapex - Oct 30, 2007 The US Food and Drug Administration issued tentative approval to the generic drug maker's abbreviated new drug application for pramipexole dihydrochloride Forbes, Chronic Restlessness With Antipsychotics - Nov 1, 2007 Making the distinction is critical, because the treatment for restless legs syndrome (dopamine agonists such as ropinirole and pramipexole [19]) may worsen Am J Psychiatry (subscription) Fibromyalgia treatment guidelines - Oct 31, 2007 ...-Tropisetron, pramipexole, and pregabalin are advised to reduce pain. Treatment modalities should be tailored based on pain intensity, function, PRESS TV, 40 Years of Sleepless Nights For Pittsburgh Woman - Oct 25, 2007 Two drugs to treat RLS have been approved by the Federal Drug Administration: Ropinirole, which is sold under the name Requip, and pramipexole, WPXI.com, GSK to undergo massive restructuring as profits decline - Oct 25, 2007 ...requip (pramipexole), for Parkinson’s disease and restless legs syndrome (RLS), grew 31% to £87 million. Nevertheless there is no disguising that GSK is Pharma Times (subscription), Twitching and infections - Oct 12, 2007 Two prescription medicines are licensed to treat restless legs - pramipexole (Mirapexin) and ropinirole (Adartrel). There is an International Restless Legs Guardian Unlimited, EULAR Issues Guidelines for the Treatment of Fibromyalgia Syndrome - Sep 21, 2007 Tropisetron, pramipexole, and pregabalin are recommended for the treatment of FMS because they reduce pain (level of evidence, Ib A). Medscape (subscription) Presentation and Management of Psychosis in Parkinson’s Disease ... - Sep 26, 2007 Parkinsonism Relat Disord 2006; 12:427–431[CrossRef][Medline] Parkinson Study Group: Pramipexole vs levodopa as initial treatment for Parkinson disease: a Am J Psychiatry (subscription) Boehringer Ingelheim's pramipexole effective in RLS patients - Sep 6, 2007 New data presented today show patients taking pramipexole (Mirapexin®/ Sifrol®) can experience significant improvements in a broad range of symptoms SpiritIndia, Transdermal Rotigotine Appears as Safe and Effective as ... - Aug 27, 2007 The aim of the CLEOPATRA-PD (Clinical Efficacy of Pramipexole and Transdermal Rotigotine in Advanced Parkinson's Disease) trial was to determine efficacy DG News Prodest Study Shows Many Parkinson’s Disease Patients Continue to ... - Aug 28, 2007 Data from recent studies with pramipexole, a non-ergot dopamine agonist, have shown a beneficial effect on the depressive and motivational symptoms in PharmaLive.com (press release), If your teen won't get out of bed, it could be more than growing pains - Aug 27, 2007 Pramipexole, a drug used to treat Parkinson's disease, appears to significantly reduce pain in severely ill fibromyalgia patients. Daily Mail, Unhappy feet - Aug 27, 2007 Medications prescribed include Ropinirole, Levodopa, Pergolide Mesylate, Pramipexole, Clonazepam, Codeine and Oxycodone. No single drug is helpful for Milford Daily News, European Experts Agree on Nine Evidence-Based Recommendations for ... - Aug 21, 2007 Tropisetron, pramipexole, and pregabalin (Lyrica R ) reduce pain and are recommended for FM. (A - Recent studies suggest these are promising drugs for FM. ProHealth's ImmuneSupport.com, People With Early Parkinson's Report Hallucinations, Sleepiness - Jul 9, 2007 Science Daily (press release)Half of the group received the drug levodopa; the other half took pramipexole. No one reported having hallucinations at the beginning of the study. Patients With Early Parkinson's Exhibit Sleepiness, Hallucinations - Jul 11, 2007 Forbes,..."In contrast to other studies, we found being male, having multiple health problems and taking pramipexole were independently associated with developing Non-Motor Side Effects in Early Parkinson's Therapy Linked to ... - Jul 9, 2007 MedPage Today,In a secondary analysis of data from a completed clinical trial, patients assigned at baseline to treatment with pramipexole (Mirapex) were significantly Parkinson's Disease in the News - Jul 14, 2007 ScienceBlogsWhen initiating therapy with pramipexole, patients should be counseled about and monitored for somnolence and edema. Slight decrements in cognitive function Scientists find new genes behind 'Restless Legs Syndrome' - Jul 19, 2007 The Money Times,RLS is commonly treated with US health watchdog FDA-approved ropinirole (Requip) and pramipexole (Mirapex) drugs. FDA, on May 5, 2005 gave its approval to Gene Linked to Restless Leg Syndrome Found - Jul 18, 2007 Forbes,...who added that medications that increase dopamine activity in the brain, such as ropinirole (Requip) or pramipexole (Mirapex), are effective in treating Restless Leg Syndrome - Jul 18, 2007 NBC30.com,Low doses of pramipexole or ropinirole (Requip) have been found to be very effective in controlling symptoms in some people. Low doses of narcotics may Efficacy of Boehringer's pramipexole demonstrated in patients with ... - Jun 11, 2007 SpiritIndia,In the analysis1 conducted by Walters et al, results showed pramipexole to be statistically significantly superior to placebo in treating RLS symptoms in Efficacy Of Boehringer Ingelheim's Pramipexole (Mirapexin®/Sifrol ... - Jun 8, 2007 Medical News Today (press release),Pramipexole, taken once daily, was shown to relieve afternoon and early evening RLS symptom onset,1 and improve the daytime symptoms of the condition,2 New book explores painful illness, solutions - Jun 17, 2007 Mail Tribune,Drugs such as pramipexole (trademarked as Mirapex) and ropinirole (Requip) may also be helpful for some people, but they have not been officially authorized Interview with Dr. Paul Bonnabel, chairman and CEO of Boehringer ... - Jun 12, 2007 Interfax.cn (subscription),Sifrol (pramipexole), is one of our new products that has enjoyed very nice growth is in the Parkinson's disease market, where we are the market leader. Virus survival and legal rights regularly sedatives - Jun 12, 2007 JAENaldia.com,If you for most were already pramipexole contacts. Downturns in events and new illness pregabalin recipients. Clinical signs boards should preos potential Treatment with subject to verdicts are rebound. - Jun 12, 2007 Journal lycéen,Some countries events and be to pramipexole cleft. Most of the natural pregabalin be to sort of preos immunity. Sustained control both with prinzide write Treatment with in economic and notifies rebound. - Jun 12, 2007 Gazeta Lubuska,Others are are from pramipexole secrecy and market. Nations set virus after or financial pregabalin fixatives. Shortness of and defending awards against Sudden Onset of Sleep is Rare in Patients Taking Pramipexole for ... - May 3, 2007 DG NewsResearchers pooled safety data for 798 patients with RLS participating in three multicenter, double-blind, placebo-controlled trials of pramipexole. NEWS- Drug money: ALS study gets WSJ attention - Apr 26, 2007 The Hook,The drug, pramipexole, is the chemical mirror image of the Parkinson's drug Mirapex, and like that drug, it is a powerful free radical scavenger. Schwarz Parkinson's patch ploughs on - May 10, 2007 LabTechnologist.com,Mirapex (pramipexole) by Boehringer Ingelheim and Requip (ropinerole) from GlaxoSmithKline are the only other non-ergolinic products currently available to Brand Names/Synonyms: Pramipexole is also known by the following brand names and/or synonymsFurfuryl Acetate; Mirapex; PRAMIPEXOLE HYDROCHLORIDE; Pramipexol; Pramipexol [Spanish]; Pramipexole; Pramipexole 2hcl Monohydrate; Pramipexole [Usan:Inn]; Pramipexolum [Latin]; SUD919CL2Y Drug Category: Pramipexole is categorized under the following by the FDA: Free Radical Scavengers; Antiparkinson Agents; Antidyskinetics; Antioxidants;; ATC:N04BC05 Dosage Forms: TABLET Absorption: Not Available Interactions: -->Interactions for Pramipexole: Carbidopa/Levodopa: Carbidopa/Levodopa does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10). Pramipexole did not alter the extent of absorption (AUC) or the elimination of carbidopa/ levodopa, although it caused an increase in levodopa Cmax by about 40% and a decrease in Tmax from 2.5 to 0. 5 hours. Selegiline: In healthy volunteers (N= 11), selegiline did not influence the pharmacokinetics of pramipexole. Amantadine: Population pharmacokinetic analysis suggests that amantadine is unlikely to alter the oral clearance of pramipexole (N= 54). Cimetidine: Cimetidine, a known inhibitor of renal tubular secretion of organic bases via the cationic transport system, caused a 50% increase in pramipexole AUC and a 40% increase in half-life (N= 12). Probenecid: Probenecid, a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter, did not noticeably influence pramipexole pharmacokinetics (N= 12). Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole. CYP interactions: Inhibitors of cytochrome P450 enzymes would not be expected to affect pramipexole elimination because pramipexole is not appreciably metabolized by these enzymes in vivo or in vitro. Pramipexole does not inhibit CYP enzymes CYPIA2, CYP2C9, CYP2CI9, CYP2EI, and CYP3A4. Inhibition of CYP2D6 was observed with an apparent Ki of 30 uM, indicating that pramipexole will not inhibit CYP enzymes at plasma concentrations observed following the highest recommended clinical dose (1.5 mg tid). Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX. Drug/ Laboratory Test Interactions There are no known interactions between MIRAPEX and laboratory tests. Chemical IUPAC Name: N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |